1.
Bolaños-Díaz R, Tejada RA, Sanabria C, Escobedo-Palza S. Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: entecavir and tenofovir. Rev Peru Med Exp Salud Publica [Internet]. 2017 Sep. 29 [cited 2024 Nov. 12];34(3):377-85. Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/2496